212 related articles for article (PubMed ID: 29460735)
21. Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing.
Namburete EI; Tivane I; Lisboa M; Passeri M; Pocente R; Ferro JJ; Harrison LH; Bollela VR
BMC Infect Dis; 2016 Aug; 16():423. PubMed ID: 27534745
[TBL] [Abstract][Full Text] [Related]
22. Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011.
Ruesen C; van Gageldonk-Lafeber AB; de Vries G; Erkens CG; van Rest J; Korthals Altes H; de Neeling H; Kamst M; van Soolingen D
Euro Surveill; 2014 Mar; 19(11):. PubMed ID: 24679720
[TBL] [Abstract][Full Text] [Related]
23. Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014.
Smith CM; Trienekens SC; Anderson C; Lalor MK; Brown T; Story A; Fry H; Hayward AC; Maguire H
Euro Surveill; 2017 Feb; 22(8):. PubMed ID: 28251890
[TBL] [Abstract][Full Text] [Related]
24. Antituberculosis drug-resistance surveillance as a tool for tuberculosis control programmes: a retrospective study.
La Raja M; Screm C; Talmassons G; Pasquadibisceglie A; Pitzalis G; Pitzus E
Monaldi Arch Chest Dis; 1997 Oct; 52(5):450-4. PubMed ID: 9510665
[TBL] [Abstract][Full Text] [Related]
25. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia.
Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S
Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208
[TBL] [Abstract][Full Text] [Related]
26. Trends in, and factors associated with, HIV infection amongst tuberculosis patients in the era of anti-retroviral therapy: a retrospective study in England, Wales and Northern Ireland.
Winter JR; Stagg HR; Smith CJ; Lalor MK; Davidson JA; Brown AE; Brown J; Zenner D; Lipman M; Pozniak A; Abubakar I; Delpech V
BMC Med; 2018 Jun; 16(1):85. PubMed ID: 29879977
[TBL] [Abstract][Full Text] [Related]
27. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
28. Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.
Gautam SS; Mac Aogáin M; Cooley LA; Haug G; Fyfe JA; Globan M; O'Toole RF
PLoS One; 2018; 13(2):e0192351. PubMed ID: 29466411
[TBL] [Abstract][Full Text] [Related]
29. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
Bang D; Lillebaek T; Thomsen VØ; Andersen AB
Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
[TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates.
Ho J; Jelfs P; Sintchenko V
Int J Infect Dis; 2014 Sep; 26():149-53. PubMed ID: 25086437
[TBL] [Abstract][Full Text] [Related]
31. Resistance to anti-tuberculosis medications in the Horn of Africa.
Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for drug resistant tuberculosis in southeast Turkey.
Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
[TBL] [Abstract][Full Text] [Related]
33. Burden of Multidrug Resistant Mycobacterium tuberculosis Among New Cases in Al-Madinah Al-Monawarah, Saudi Arabia.
Elhassan MM; Hemeg HA; Elmekki MA; Turkistani KA; Abdul-Aziz AA
Infect Disord Drug Targets; 2017; 17(1):14-23. PubMed ID: 27848902
[TBL] [Abstract][Full Text] [Related]
34. Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
Rando-Segura A; Aznar ML; Moreno MM; Espasa M; Sulleiro E; Bocanegra C; Gil E; Eugénio ANE; Escartin C; Zacarias A; Vegue J; Katimba D; Vivas MC; Gabriel E; Marina MC; Mendioroz J; López MT; Pumarola T; Molina I; Tórtola MT
Emerg Infect Dis; 2018 Mar; 24(3):569-572. PubMed ID: 29460748
[TBL] [Abstract][Full Text] [Related]
35. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
[TBL] [Abstract][Full Text] [Related]
36. Acquired Resistance to Antituberculosis Drugs.
Aung HL; Nyunt WW; Fong Y; Russell B; Cook GM; Aung ST
Emerg Infect Dis; 2018 Nov; 24(11):2134. PubMed ID: 30334732
[No Abstract] [Full Text] [Related]
37. Incidence and risk factors for drug intolerance and association with incomplete treatment for tuberculosis: analysis of national case registers for England, Wales and Northern Ireland, 2001-2010.
Smith C; Abubakar I; Thomas HL; Anderson L; Lipman M; Reacher M
Thorax; 2014 Oct; 69(10):956-8. PubMed ID: 24334518
[TBL] [Abstract][Full Text] [Related]
38. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
40. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
